 |
Leadership & Management
Board of Directors
Steven B. Gerber, M.D.
Chairman of the Board
HemaCare Corporation
Dr. Gerber was elected Chairman of the Board in May, 2009, and has
been a director of the Company since 2003. A board-certified Internist
and Cardiologist with subspecialty training in Nuclear Cardiology,
Dr. Gerber earned his BA in Psychology at Brandeis University, his
MD at Tufts University, and his MBA at UCLA. Dr. Gerber is currently
a board member and audit committee chair for privately-held iTherX
Pharmaceuticals, a member of the Board of Overseers at Tufts University
School of Medicine, and a Medical Expert for the U.S. Social Security
Administration. In October 2007, Dr. Gerber successfully completed
the UCLA Directorship Training and Certification Program. Dr. Gerber
is Chairman of the Audit Committee and a member of the Quality Assurance
and Corporate Governance and Nominating Committees.
Julian Steffenhagen
Director
HemaCare Corporation
Mr. Steffenhagen served as Chairman of the Board from September 2002
to May 2009 and as Interim Chief Executive Officer from June 2007
to September 2008. He joined the board of directors in 1997. Over
a period of 27 years, Mr. Steffenhagen held several management positions
at Beckman Coulter, Inc., an international manufacturer of systems
for biomedical testing in life sciences research and clinical diagnostics.
At his retirement in January 2007, he held the position of Senior
Vice President. He earned his Bachelor of Science and Master of Science
degrees in mechanical engineering, and his Master of Business Administration
degree from the University of Michigan. Mr. Steffenhagen has served
on the Audit and Compensation Committees and currently is a member
of the Quality Committee.
Terry Van Der Tuuk
President
VanKan, Inc.
Terry Van Der Tuuk has been a director of the Company since May 2003.
Mr. Van Der Tuuk founded Graphic Technology, Inc. in 1978. He took
it public in 1983 as Chairman and President. In 1989, he sold the
Company to Nitto Denko of Osaka, Japan and continued as Vice Chairman
until 2003, when he retired from GTI. He is President of VanKan, Inc,
a Kansas based venture capital firm which invests in privately held
companies in the Midwest area. Mr. Van Der Tuuk served on several
educational boards, including The Wharton School, University of Pennsylvania,
and currently serves on the boards of several privately held companies.
Mr. Van Der Tuuk received his Bachelor of Science degree from Michigan
State University and his Masters of Business Administration degree
from The Wharton School, University of Pennsylvania. Mr. Van Der Tuuk
is a member of the Audit and Compensation Committees.
Teresa
S. Sligh, MD
President and Medical Director
Translational Research Group, Inc.
Teresa S. Sligh, MD has been a director of the Company since May 2006.
Since 2003, Dr. Sligh has been the President and Medical Director
of Translational Research Group, Inc. and has served as the Chief
Medical/Strategy Officer for Capital Technology Information Services,
Inc. Dr. Sligh completed two years of post graduate medical training
in Internal Medical at Presbyterian Hospital of Dallas, Texas, and
received her M.D. degree at Texas A&M College of Medicine. She received
her Bachelor of Science degree in biochemistry from the University
of New Mexico. Dr. Sligh is the Chairwoman of the Quality Assurance
Committee and a member of the Compensation Committee.
Pete
van der Wal
President and CEO
HemaCare Corporation
Executive Officers
Pete van der Wal
President and CEO
HemaCare Corporation
Pete van der Wal, formerly HemaCare’s Vice President of Sales
and Marketing, has been named President and CEO and was appointed
to the Company’s Board of Directors on March 1, 2010. Mr. van
der Wal has a proven track record with over 20 years of success managing
sales, marketing, operations, and business development in the medical
services industry. He has held senior management positions with Comprehensive
Imaging Solutions, Phormax Corporation, Comprehensive Medical Imaging,
and Syncor International Corporation. He received his Masters in Business
Administration from George Mason University and Bachelor of Science
degree from the University of Maryland.
Medical Directors
Melanie Osby, MD
National Medical Director
HemaCare Corporation
Dr. Osby currently serves as the consulting National Medical Director
of HemaCare Corporation having joined in 2006 as the Assistant Medical
Director. Dr. Osby is board certified by the American Board
of Pathology in Anatomic and Clinical Pathology and Transfusion
Medicine. She completed her Anatomic and Clinical Pathology
training at LAC+USC Medical Center and Transfusion Medicine clinical
fellowship training at Cedars Sinai Medical Center. Dr. Osby
maintains a full-time position with the County of Los Angeles Department
of Health Services, in the Department of Pathology at LAC+USC Medical
Center. Dr. Osby has voluntary faculty privileges at the University
of Southern California in the Department of Pathology and at the
Charles R. Drew University of Medicine and Science. She is
a member of many medical societies, including the AABB, California
Blood Bank Society, American Society for Apheresis, and the College
of American Pathologists for which she serves as the Division Commissioner
for Southern California. She has authored several articles
in peer-reviewed journals, including Archives of Pathology &
Laboratory Medicine and Transfusion. She earned her B.A. and
M.S. in Microbiology from California State University, Los Angeles
and her M.D. from the Drew/UCLA School of Medicine.
David Ciavarella, MD
Medical Director
Coral Blood Services
Dr. Ciavarella joined Coral Blood Services (then called Coral Therapeutics)
as Medical Director in January 1995. Prior to joining Coral, Dr.
Ciavarella served as Vice President of the New York Blood Center,
the largest independent blood center in the U.S., where he managed
the Hudson Valley Blood Services division and served as Director
for Transfusion Services at Westchester County Medical Center, New
York Medical College. He is a member of many professional societies
and past president (1994-1995) of the American Society for Apheresis.
He is board certified in Internal Medicine and Hematology and an
Instructor at Harvard Medical School. Dr. Ciavarella earned his
B.Sc. in Chemistry at Stanford University and his M.D. degree at
the University of California, Los Angeles.
Jacquelyn Hedlund, MD
Medical Director
Coral Blood Services
Dr. Hedlund joined Coral Blood Services (then called Coral Therapeutics)
as an Associate Medical Director in 1996 and currently serves as
a consulting Medical Director. She practices hematology at
the Maine Center for Cancer Medicine and is the Medical Director
of the Maine Medical Center Cancer Institute. She graduated with
a B.A. in Economics from Smith College and earned an M.S. in Health
Policy and Management from the Harvard School of Public Health.
She completed medical school at the University of Vermont College
of Medicine; hematology training at the University of Washington
in Seattle; and transfusion medicine training at the Puget Sound
Blood Center. Currently, she is board certified in Internal Medicine
and Hematology.
|
|
